Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13058-015-0548-5
Published Online: 2015-03-26
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Tinholt, Mari
Vollan, Hans Kristian Moen
Sahlberg, Kristine Kleivi
Jernström, Sandra
Kaveh, Fatemeh
Lingjærde, Ole Christian
Kåresen, Rolf
Sauer, Torill
Kristensen, Vessela
Børresen-Dale, Anne-Lise
Sandset, Per Morten
Iversen, Nina
License valid from 2015-03-26